Charlie Health reports that eating disorders are significantly influenced by genetics, with family history increasing risk ...

Binge eating disorder (BED) ... Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations.

A growing number of people are struggling with their relationship with food in ways that don’t always meet the criteria for ...

Eating Disorder Treatment Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The binge-eating disorder treatment market is set to expand significantly, with an anticipated growth ...

Rutgers Health researchers have uncovered mixed outcomes for patients using lisdexamfetamine, a stimulant commonly prescribed for binge eating disorder (BED). The study, led by Abanoub Armanious ...

In a 12-week study of 23 women with nonpurging bulimia, McCann and Agras reported that desipramine reduced binge eating by 63% compared with a 6% increase reported with placebo.

Charlie Health reports that summer intensifies body image concerns and eating disorders, especially among young people and ...

Vyvanse isn't a new drug, but the FDA approved it as a treatment for binge eating disorder ... In one study, 255 people got different doses of either Vyvanse or a placebo with no medicine.

The study, published online ahead of press in the December 2024 edition of Psychiatry Research Communications, explores the ...

The goal of the study was to identify and categorize the diverse range ... In addition, 53.9% had bulimia nervosa and 4.8% had a binge eating disorder. The most frequently cited behaviors included ...

One of the few studies that has been done on binge eating disorder and these medications looked at 48 patients with the condition who were treated at an obesity medicine clinic.

Long overlooked in women 40 and older, midlife eating disorders are going up. Eating disorder specialists cite hormonal ...